Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Spinal Cord Injuries × rimabotulinumtoxinB × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Wounds and Injuries 1 Stroke 1 Spinal Cord Injuries 1 Neoplasms 1 Muscular Atrophy 1 Muscle Spasticity 1 Brain Injuries 1

Interventions

rimabotulinumtoxinB 1 OM 89 1 Neurofeedback 1 N-(4-((5-(hydroxy(phenyl)methyl)pyrrolidin-2-yl)methyl)phenyl)-4-oxo-4,6,7,8-tetrahydropyrrolo(1,2-a)pyrimidine-6-carboxamide 1 Music Therapy 1 Cholecalciferol 1 Botulinum Toxins, Type A 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02052024 2015-12-16

MAS

Georgetown University

Phase 4 Completed

Brain Injuries, Muscle Spasticity, Muscular Atrophy, Neoplasms, Spinal Cord Injuries, Wounds and Injuries, Stroke

Data powered by HemOnc (CC BY 4.0) Colophon ⚡